Announce Date | 05/27/2025 |
EPS Normalized Actual | $0.3 (Beat by $0.02) |
EPS GAAP Actual | $0.3 (Beat by $0.02) |
Revenue Actual | $0.039107B |
Revenue Surprise | Beat by $39.107M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.31 |
EPS GAAP Estimate | $0.31 |
Revenue Estimate | $0.037778B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 1.3 | 19.65 | 1.3 | 1.3 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.28 | 0 | 0.039107B | 2.69% | 2.15M |
FQ4 2024 (Dec 2024) | 0.38 | 0.1 | 0.041664B | 11.31% | 4.18M |
FQ3 2024 (Sep 2024) | 0.41 | 0.13 | 0.039069B | -24.43% | 1.6M |
FQ2 2024 (Jun 2024) | 0.2 | -0.08 | 0.037615B | -0.1% | 0.57M |
FQ1 2024 (Mar 2024) | 0.32 | 0.02 | 0.038055B | 100% | 0.79M |
FQ4 2023 (Dec 2023) | 0.28 | -0.02 | 0.03695B | 100% | -0.37M |
FQ3 2023 (Sep 2023) | -0.04 | -0.15 | 0.048614B | 100% | 18.12M |
FQ2 2023 (Jun 2023) | 0.31 | 0.13 | 0.037653B | 100% | 4.7M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
0.31
Consensus Revenue Estimates
0.037778B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 0.25 | -- | 0.25 | 0.25 | 1 |
FQ3 2026 (Sep 2026) | 0.34 | -- | 0.34 | 0.34 | 1 |
FQ2 2026 (Jun 2026) | 0.28 | -- | 0.28 | 0.28 | 1 |
FQ1 2026 (Mar 2026) | 0.29 | 3.45 | 0.29 | 0.29 | 1 |
FQ4 2025 (Dec 2025) | 0.26 | -46.15 | 0.26 | 0.26 | 1 |
FQ3 2025 (Sep 2025) | 0.31 | -32.26 | 0.31 | 0.31 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 0.03B | -- | 0.03B | 0.03B | 1 |
FQ3 2026 (Sep 2026) | 0.04B | -- | 0.04B | 0.04B | 1 |
FQ2 2026 (Jun 2026) | 0.04B | -- | 0.04B | 0.04B | 1 |
FQ1 2026 (Mar 2026) | 0.04B | -5.94 | 0.04B | 0.04B | 1 |
FQ4 2025 (Dec 2025) | 0.04B | -16.77 | 0.04B | 0.04B | 1 |
FQ3 2025 (Sep 2025) | 0.04B | -3.42 | 0.04B | 0.04B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
3
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.28 | 0.28 | 0 | 0% |
FQ4 2024 (Dec 2024) | 0.28 | 0.38 | 0.1 | 26.32% |
FQ3 2024 (Sep 2024) | 0.28 | 0.41 | 0.13 | 31.71% |
FQ2 2024 (Jun 2024) | 0.28 | 0.2 | -0.08 | -40% |
FQ1 2024 (Mar 2024) | 0.3 | 0.32 | 0.02 | 6.25% |
FQ4 2023 (Dec 2023) | 0.3 | 0.28 | -0.02 | -7.14% |
FQ3 2023 (Sep 2023) | 0.11 | -0.04 | -0.15 | 375% |
FQ2 2023 (Jun 2023) | 0.18 | 0.31 | 0.13 | 41.94% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0.04B | $0.04B | $2.15M | 5.49% |
FQ4 2024 (Dec 2024) | $0.04B | $0.04B | $4.18M | 10.03% |
FQ3 2024 (Sep 2024) | $0.04B | $0.04B | $1.6M | 4.09% |
FQ2 2024 (Jun 2024) | $0.04B | $0.04B | $0.57M | 1.51% |
FQ1 2024 (Mar 2024) | $0.04B | $0.04B | $0.79M | 2.08% |
FQ4 2023 (Dec 2023) | $0.04B | $0.04B | $-0.37M | -1% |
FQ3 2023 (Sep 2023) | $0.03B | $0.05B | $18.12M | 37.27% |
FQ2 2023 (Jun 2023) | $0.03B | $0.04B | $4.7M | 12.47% |